Protein aggregation is a hallmark of many diseases but also underlies a wide range of positive cellular functions. This phenomenon has been difficult to study because of a lack of quantitative and high-throughput cellular tools. Here, we develop a synthetic genetic tool to sense and control protein aggregation. We apply the technology to yeast prions, developing sensors to track their aggregation states and employing prion fusions to encode synthetic memories in yeast cells. Utilizing high-throughput screens, we identify prion-curing mutants and engineer ''anti-prion drives'' that reverse the non-Mendelian inheritance pattern of prions and eliminate them from yeast populations. We extend our technology to yeast RNA-binding proteins (RBPs) by tracking their propensity to aggregate, searching for co-occurring aggregates, and uncovering a group of coalescing RBPs through screens enabled by our platform. Our work establishes a quantitative, high-throughput, and generalizable technology to study and control diverse protein aggregation processes in cells.
INTRODUCTION
Cellular aggregates are associated with many diseases, including neurodegeneration (Aguzzi and Lakkaraju, 2016) , type 2 diabetes (Mukherjee et al., 2015) , systemic amyloidosis (Blancas-Mejía and Ramirez-Alvarado, 2013) , and even aging (Ló pez-Otín et al., 2013). However, it is also becoming clear that protein aggregates have beneficial functions in many biological processes. These functions include signal transduction in the human immune system (Cai et al., 2014; Franklin et al., 2014) , synaptic regulation and memory (Majumdar et al., 2012) , RNA regulation in the cellular stress response (Han et al., 2012; Protter and Parker, 2016) , melanin production (Fowler et al., 2006) , and microbial biofilm formation (Taglialegna et al., 2016) .
Broadly, aggregation is the assembly of proteins into large complexes that can grow without a fixed endpoint. Aggregates can differ from one another in conformational diversity, size, and the diversity of components. All these factors render typical structural techniques inapplicable. Correspondingly, methods to describe protein aggregation in vivo are largely qualitative and ad hoc. Quantitative and high-throughput techniques to study aggregation are urgently needed to discover treatments for pathological aggregates and interrogate functional aggregates.
Since their discovery as the causative agents of transmissible neurodegenerative disorders, prions have served as model protein aggregates. Prions are self-propagating protein conformations found across model organisms, from bacteria to mammals. Much of what we know about prions comes from studies in yeast, where some endogenous proteins can switch from nonprion conformations to prion aggregate conformations, resulting in dramatic changes in protein activity. This switching produces new, heritable phenotypes (Halfmann et al., 2012; True and Lindquist, 2000) . Because the aggregated prion conformation is transmitted through the cytoplasm, they and their associated phenotypes are inherited in a non-Mendelian fashion (Wickner, 1994) . Tools to detect and manipulate prions in a variety of contexts are necessary to comprehensively explore their adaptive traits and potentially exploit them to engineer new cellular functionalities.
The ability of most yeast prions to adopt the prion state in cells is mediated by ''prion domains'' (PrDs) that can nucleate and propagate amyloid conformations. The observation that many known yeast prions harbor PrDs rich in glutamine (Q) and/or asparagine (N) residues has motivated the development of algorithms to look for such sequences across all proteomes (Alberti et al., 2009 ).
In the human proteome, 240 genes contain prion-like, Q/N-rich sequences (March et al., 2016) . These genes are heavily enriched for RNA-binding and RNA-processing activity, including many aggregation-prone proteins associated with fatal neurodegenerative diseases (Harrison and Shorter, 2017) . However, natural assemblies/aggregates of RNA-binding proteins (RBPs) are important for RNA storage, processing, and degradation (Protter and Parker, 2016) . RBP assemblies are also involved in the regulation of synaptic long-term potentiation (Majumdar et al., 2012) , memory in yeast (Caudron and Barral, 2013) , and the cellular stress response (Riback et al., 2017) . Factors involved in the transition of RBPs from their natural context to disease-associated aggregates remain poorly understood, as do the immediate consequences of aggregation.
Here, we use synthetic biology to develop a versatile genetic toolkit for quantitatively sensing and controlling protein aggregation states in cells. yTRAP (yeast transcriptional reporting of aggregating proteins) is based on coupling the solubility state of a protein-of-interest to the regulation of synthetic transcriptional outputs. We first use yTRAP to construct prion sensors and track prion states in live cells. Next, we use yTRAP in conjunction with a potent inducer of the [PSI + ] prion to engineer synthetic memory in yeast cells. Additionally, using yTRAP to screen mutant libraries of prions, we select for mutant prion alleles that cure endogenous [PRION + ] states.
Using these alleles, we construct ''anti-prion drive'' systems to cure prions and reverse the dominant inheritance of prion states in mating partners and progeny. We then employ yTRAP as a screening platform to detect factors that influence the aggregation of yeast RBPs, including the closest yeast homolog of hnRNPA1, Hrp1, and investigate the consequences of its aggregation. Our results establish a generalizable cell-based technology with which to observe, screen, and manipulate protein aggregation.
RESULTS

Development of a Genetic Tool that Sensitively Detects Protein Aggregation States
To detect protein aggregation in living cells, we developed a genetic tool termed yTRAP. The yTRAP cassette comprises (1) a ''yTRAP fusion'' of the protein-of-interest with a synthetic transcriptional activator (synTA), constitutively expressed at low levels and (2) a reporter gene regulated by a synTA-responsive promoter (Figures 1A and S1A) . The system functions by linking transcriptional activation of the reporter to the solubility of the yTRAP fusion. In the soluble state, the synTA binds to its cognate promoter and induces strong expression of the reporter gene. Aggregation of the fusion protein limits the availability of the synTA to regulate its promoter, thus reducing the transcriptional output of the system. The synthetic fusion can either join existing aggregates endogenous to the cell, or be the sole source of a heterologous aggregating protein. Moreover, the synTAs utilize engineered zinc-finger proteins that target synthetic binding sequences (BS); the modular design of these regulators enables yTRAP fusions to be readily constructed for any protein and the customization of transcriptional outputs (Khalil et al., 2012) . We first determined the yTRAP reporter output for different levels of soluble synTA. Using an estradiol-inducible system (Aranda-Díaz et al., 2017), we titrated synTA protein level in the cell and measured the corresponding reporter output using flow cytometry. This revealed a linear relationship between soluble synTA protein levels and reporter outputs across a $50-fold dynamic range, with only 1.5% basal expression of the reporter gene in the absence of synTA ( Figure S1B ).
To validate the tool, we applied yTRAP to detect the well-established yeast prion [PSI + ] formed by self-templating aggregates of Sup35. The yTRAP fusion consists of the Sup35 prion domain (NM) fused to a synTA. Sup35, like several other prion proteins, can adopt multiple self-templating amyloid conformations, producing varied ratios of soluble/aggregated protein in the cell. We introduced the ''PSI sensor'' into three yeast strains representing variants of this prion: strong [ ] state using semi-denaturing detergent agarose gel electrophoresis (SDD-AGE) ( Figure 1B ) (Halfmann and Lindquist, 2008) . Previous methods to detect a prion state have relied on the use of genetic backgrounds that change cellular phenotypes upon changes to the prion state. (Halfmann et al., 2012; True and Lindquist, 2000) . Uniquely, yTRAP allows batch or single-cell measurement of aggregation state independent of the genetic background ( Figure S1E ). Taken together, these results demonstrate that yTRAP is a highly sensitive genetic sensor that can quantitatively distinguish between prion states. Figure 1D ). Extending this general approach, we built sensors for a panel of other yeast prion proteins: Swi1, Mot3-PrD, and New1-PrD (Alberti et al., 2009; Du et al., 2008; Osherovich and Weissman, 2001) . Importantly, with these sensors, we were able to not only detect existing prion states, but also to isolate newly formed prion states and subsequently observe their curing by Hsp104 inhibition ( Figures S1C and S1F) . These results establish a synthetic, ''plug-and-play'' toolkit for detecting and isolating prion states, applicable for different prions and across genetic backgrounds.
Next, we explored whether yTRAP could be used to interrogate the aggregation of human disease proteins using the huntingtin protein associated with Huntington's disease as a Relative aggregation of each sensor was measured after overexpression of Htt-Q103 (n = 3; error bars, SD). See also Figure S1 and Tables S4 and S5. model system. Individuals with longer polyglutamine (poly(Q)) tracts produce more aggregation-prone protein. We compared the solubility of yTRAP sensors for a highly poly(Q)-expanded huntingtin exon 1 (Htt-Q103, containing 103 glutamine residues) to a shorter expansion (Htt-Q25). Both yTRAP fusion proteins were expressed at the same level, yet yTRAP sensor outputs confirmed that Htt-Q103 was more aggregated than Htt-Q25 ( Figure S1G ).
Poly(Q) aggregates have been shown to sequester other cellular proteins, a property that likely contributes to their toxicity (Gong et al., 2012; Park et al., 2013; Wang et al., 2007) . We generated yTRAP sensor strains for a panel of previously characterized Q-and N-rich yeast protein fragments, pairs of which differ only in Q/N content (Halfmann et al., 2011) , and measured the change in yTRAP signal in response to Htt-Q103 overexpression. Note that although both Q-and N-rich proteins are aggregation prone, only Q-rich proteins were previously observed to co-localize with Htt-Q103 (Kayatekin et al., 2014) . As assessed by yTRAP, Q-rich proteins showed a marked shift to an aggregated state when Htt-103Q was expressed, whereas matched N-rich control proteins were unaffected ( Figure 1E ). Our results support the model that Q-rich proteins are particularly susceptible to sequestration by poly(Q)-expanded huntingtin and illustrate the potential of yTRAP to screen for factors that influence disease-relevant aggregation.
Positive Detection of Aggregation and Multiplex Tracking of Prion States
The yTRAP tool is built from programmable synthetic components. As a result, yTRAP-based genetic circuits can be constructed to produce custom sensor programs. For example, we designed a sensor system with reverse output logic, which turns ON upon aggregate formation. In the ''reverse-yTRAP'' scheme, the synTA-responsive promoter controls expression of a TetR repressor (fused to mKate2), which in turn regulates a Tet-repressible reporter (Figures S2A and S2B) . When the yTRAP fusion protein is soluble, TetR-mKate2 is expressed and the reporter is repressed. This repression is relieved when the yTRAP fusion is aggregated. We built and introduced a Rnq1 reverse-yTRAP sensor into [RNQ + ] and [rnq - ] cells, revealing strongly separated high green/low red and low green/high red fluorescent states, respectively ( Figure S2A ). By adding a second fluorescent output, which gains signal upon aggregation, the reverse-yTRAP system enhances measurement sensitivity, especially in detection of the onset of aggregation. Figure S2 and Tables S4 and S5. The study of prions in high throughput has been limited to interrogating the behavior of individual prions, partly because each yeast prion has required a tailored genetic background for detection. By unlocking additional synthetic transcriptional channels, yTRAP enables the tracking of multiple prion proteins at the single-cell level. To do this, we designed a ''dual prion sensor'' by utilizing two orthogonal pairs of synTAs/responsive promoters (Khalil et al., 2012) . The dual prion sensor consists of two cassettes, each encoding (1) a yTRAP fusion comprising a protein-of-interest fused to a distinct synTA and (2) a corresponding synTA-controlled unique reporter (Figures 2A and S2C) . We used this framework to develop a dual PSI/RNQ sensor (Figures 2A and 2B ). With the availability of a suite of orthogonal synTA-promoter pairs (Khalil et al., 2012) , we envision these yTRAP combinations can be expanded to allow greater numbers of proteins to be simultaneously monitored.
A B C
Next, we sought to apply the dual PSI/RNQ sensor to simultaneously track the behavior of these two prions in response to a stimulus. We subjected a population of [PSI + ] [RNQ + ] cells to guanidine hydrochloride treatment, took samples at different durations of treatment, and allowed them to recover in growth media lacking guanidine for a minimum of six generations. We then assessed prion states using flow cytometry ( Figure 2C , left). We could readily distinguish combinations of prion / nonprion states that were sampled by the population as it progressed from entirely [ Figure 2C ). ] is more readily cured by guanidine hydrochloride, as has been previously reported (Derkatch et al., 2000) . induction efficiency to $10% using a Sup35NM-Rnq1 fusion (NM-Rnq1) (Choe et al., 2009) . We sought to improve its efficiency by tethering the two amyloid-forming domains even closer together, creating N-Rnq1-M ( Figure 3A Figure S3 and Tables S4 and S5. of these strains to a 2-hr stimulus of elevated temperature between a range of 30 C and 38 C. We then recovered the cells for over 10 generations at 25 C and measured the percentage of the population that switched to [PSI + ].
As the temperature increased, so did the proportion of the N-Rnq1-M expressing population that had induced and maintained the [PSI + ] prion ( Figure 3C ). In contrast, the NMinducing control strain showed no [ ( Figure 4A ). We mated cells containing libraries of Sup35 and Rnq1 mutants (Huang et al., 2013) We recovered many of the previously reported prion-curing alleles of Sup35 (DePace et al., 1998) , including Q10R, Q15R, and Q24R ( Figure 4B ). We also recovered several new alleles, notably the first that do not involve the introduction of a charged residue: Q61L and the double mutant Y46C, Q95L.
The screen for [RNQ + ]-curing alleles yielded two variants: D288-298 and a nonsense mutation resulting in a truncated protein at amino acid 313 (stop313) ( Figure 4C ). The D288-298 deletion spans an oligopeptide repeat and was previously identified as a naturally occurring allele in S. cerevisiae (Resende et al., 2003 Figure S4 ). The two exceptions were the double mutant S17R, Q56R and the double mutant Q10R, Q24R. Our results illustrate the potential of yTRAP to enable high-throughput screens for aggregation-modifying factors.
Anti-prion Drive Systems Engineered Using PrionCuring Alleles Gene drives are genetic systems that bias the standard Mendelian inheritance of a particular gene to increase its prevalence in a population (DiCarlo et al., 2015) . Prion-curing mutant alleles offer a unique opportunity to reverse the typical 4:0 phenotypic inheritance of the [PSI + ] and [RNQ + ] prions. If a strain is engineered to express a prion-curing mutant, it will cure the prion that is present in its mating partner instead of acquiring a prion state, and future progeny will not inherit the prion ( Figure 5A ). We term this mode of inheritance an ''anti-prion drive'' (APD), as it biases the inheritance of prion phenotypes from 4:0 to 0:4. See also Figure S4 and Tables S1, S4, and S5.
We used the Sup35 S17R, Q56R double mutant to construct an ''anti-PSI drive'' due to its efficient and highly selective [PSI + ]-curing potential ( Figures 4B and S4) , and the stop313 Rnq1 mutant to construct an ''anti-RNQ drive.'' We cloned each prion-curing allele or a wild-type control into a plasmid with strong constitutive expression, and integrated these into the genome of a strain harboring the respective yTRAP sensor ( Figures 5B and 5C ). We then mated these strains to the corresponding [PRION + ] strain also harboring the yTRAP sensor. We selected for diploids, sporulated them, and dissected tetrads to determine the segregation frequency of the phenotype ( ] from spores that do not inherit the drive cassette (''semi-drive''). Like above for Sup35NM, wild-type Rnq1 and its guanidinecured derivatives were used as controls. See also Figure S5 and Tables S4 and S5 Figure S5D ). In contrast, spores that no longer had the anti-RNQ construct were completely cured of the [RNQ + ] prion and were not further cured on guanidine hydrochloride-containing media (Figure S5D) . This unusual inheritance pattern was confirmed by western blotting for Rnq1 following supernatant/pellet fractionation of cell extracts ( Figure S5E ). For both the anti-PSI and the anti-RNQ drives, all dissected tetrads showed the expected 2:2 segregation of the APD cassette, which allows growth on medium lacking leucine (ÀLeu) (Figure 5B) . These results suggest a mechanism of [RNQ + ] curing by the stop313 mutant, whereby the mutant causes a change in the prion conformation to one that requires the stop313 Rnq1 protein to propagate. Once that mutant allele is removed and only the wild-type Rnq1 protein remains, the new prion variant is no longer propagated. One of the RNQ1 mutant alleles identified in our screen, D288-298, is a naturally occurring variant ( Figure 4C Figure S5G ). Spores that did inherit the drive cassette showed an even greater degree of solubility. This process is reminiscent of genetic recombination, where two different parental chromosomes are mixed to produce a new, diverse haplotype. In an analogous manner, two parents with different prion alleles or conformations may interact to produce a new prion conformation that was not present in either parent.
Generation of a yTRAP Sensor Library for RBPs
The phenomenon of protein aggregation extends to many areas of biology beyond the amyloid-like aggregation observed with yeast prions, from aberrant aggregates of disease-associated misfolded proteins to controlled phase transitions in cellular droplets. yTRAP has allowed us to overcome challenges associated with traditional methods of analyzing yeast prions. Next, we sought to address challenges in studying protein aggregation more broadly with yTRAP. The aggregation of RBPs has gained recent attention as a causal agent in neurodegeneration (Li et al., 2013) and in the formation of functional, membraneless RNP bodies (March et al., 2016) . To enable quantitative analysis of RBP aggregation, we created a yTRAP sensor library encompassing every known yeast RBP with an experimentally confirmed physical interaction with RNA (Table S2) , constituting $150 sensor strains (Figure S6A) . We observed that the relative protein abundance of these RBP-synTA fusions does not correlate with their yTRAP signal ( Figure S6B ), confirming that yTRAP signal is not merely a readout of protein concentration. We also determined that none of the RBPs are likely to be in a prion state by default in this strain, as transient chaperone inhibition did not cause a heritable change in yTRAP signal ( Figure S6C ). With this collected panel of sensors, one experiment can quantitatively compare the aggregation of each RBP after chemical or genetic perturbation.
Screening for Aggregation Propensity of RBPs
We first tested the intrinsic aggregation propensity of each RBP by measuring changes in its yTRAP signal upon overexpression of the protein ( Figure 6A ). Increasing the concentration of an aggregation-prone protein favors its aggregation as per the law of mass action. Hrp1, a component of the cleavage and polyadenylation factor (CPF) complex, showed the greatest signal loss when overexpressed. We confirmed that this loss of yTRAP signal for Hrp1 and another top candidate, Ngr1, was accompanied by microscopic foci formation ( Figure 6B ). Hrp1 is the closest yeast homolog of human hnRNPA1, the aggregation of which is associated with both multisystem proteinopathy (MSP) and amyotrophic lateral sclerosis (ALS) (Harrison and Shorter, 2017) . Thus, we decided to focus on Hrp1 for further analysis.
We observed aggregation of Hrp1 during a short burst of overexpression; however, its sustained overexpression was detrimental to cell growth ( Figure S6D ). Hrp1 is predicted to possess two separate PrDs ( Figure 6B ), which may be responsible for the observed aggregation (Alberti et al., 2009 ) and toxicity. To test this, we deleted each region separately and overexpressed them with fluorescent tags. Overexpression of Hrp1 in which the downstream PrD was deleted resulted in almost no aggregation or toxicity (Figures 6B and S6D) . In contrast, removal of the upstream PrD increased both aggregation and toxicity. Furthermore, Hrp1 missing the upstream PrD sequestered endogenous Hrp1 into co-localized aggregates (Figures S6E) (we confirmed that fluorescent channel ''bleedthrough'' was negligible and not confounding) ( Figure S6F ). Thus, the upstream PrD acts as a solubilizing element, while the downstream PrD is responsible for both aggregation and toxicity.
Next, we utilized the yTRAP RBP sensor library to identify co-occurring aggregates in high throughput. We examined the effect of Hrp1 overexpression on every member of the RBP yTRAP sensor library ( Figure 6C ). Top hits that aggregated during Hrp1 overexpression were tagged at their endogenous locus with mNeonGreen to track their localization. Microscopic imaging showed distinct foci formation of Nsr1, Cbf5, and Nop58-all factors involved in ribosome biogenesis-upon Hrp1 overexpression ( Figure 6D ). These results demonstrate that yTRAP can be used to efficiently identify proteins and pathways that are perturbed upon a proteotoxic stress without a priori knowledge.
Genome-wide Screen for Modulators of Hrp1 Aggregation
We hypothesized that the cell may utilize the ability of Hrp1 to aggregate as a natural way to modulate its function. We therefore conducted a genome-wide overexpression screen in the context of the Hrp1 yTRAP sensor to identify genes that could be involved in this pathway and affect Hrp1 aggregation. We used an estradiol-inducible system to express all yeast ORFs in the FlexGene library, over 5,500 in total (Hu et al., 2007) . We mated each overexpression strain with the Hrp1 yTRAP sensor in an arrayed format and measured the change in yTRAP signal ( Figure 7A ).
We subsequently validated hits that we identified as reducing the Hrp1 yTRAP signal by more than three standard deviations (Figures S7A-S7C ; Table S3 ). Nab2 emerged as the most potent inducer of Hrp1 aggregation that also caused no change in total levels of Hrp1 ( Figures S7B and S7C ). Fluorescence microscopy of overexpressed Nab2-mKate2 and endogenous Hrp1 (tagged with mNeonGreen) showed strong aggregation and co-localization of both proteins ( Figure 7B ). In contrast to the toxicity of Hrp1 aggregation induced by its own overexpression ( Figure S6D ), Nab2 overexpression led to non-toxic Hrp1 aggregation ( Figure S7D ). This effect is specific for Hrp1, as Nab2 overexpression had no effect on two physical interactors of Hrp1 in the CPF complex, Rna14, and Rna15 ( Figure S7E ).
Hrp1 binds UA-rich elements in transcribed mRNAs and aids in orienting the CPF complex to proper mRNA cleavage/polyadenylation (poly(A)) sites. We therefore predicted that Nab2-induced aggregation of Hrp1 could affect its function and cause an alteration in 3 0 mRNA cleavage sites and thus their 3 0 UTR lengths. To test this prediction, we chose eight genes that have been reported to generate transcripts harboring variable 3 0 UTRs (Sparks et al., 1997; Yoon and Brem, 2010) and assessed their 3 0 UTR length with and without Nab2 overexpression. Indeed, five of these transcripts had differential cleavage patterns (Figure 7C) . These results suggest that Nab2 overexpression can sequester Hrp1 and lead to a change in its activity. We have developed a modular, genetic tool that enables quantitative monitoring of cellular aggregates. yTRAP represents a significant advance over existing methods to assay protein aggregates on account of its simplicity, sensitivity, speed, and low cost. A key advantage is the capability to design highthroughput screens on protein aggregation phenomena. As we demonstrated, there are many possible modes of screening. Large panels of sensors can be generated to screen for aggregation or solubilization in response to genetic or other perturbations; alternatively, one can screen the effects of entire genomes on the aggregation of individual sensors. We envision these studies could be further scaled up to screen large libraries of See also Figure S7 and Tables S3-S5. yTRAP sensors against large libraries of genetic or chemical perturbations. In this manner, networks of aggregation and assembly interactions can be mapped out to give a comprehensive view of the cellular ''aggregome.'' yTRAP features a synthetic biology design that couples protein solubility to transcriptional activity. This excludes certain proteins, such as integral membrane proteins, from compatibility with the current system. Yet an advantage of the modular design is that it enables a standard framework for all aggregation events, circumventing the need to construct novel assays for each protein of interest. Outputs can be customized with desired genetic or enzyme-based reporters. yTRAP functionality does not rely on genetic background, specific growth media, or additional reagents. Moreover, yTRAP is an in vivo tool and so does not introduce artifacts associated with lysis or reconstitution of components out of a cellular context. Finally, the orthogonal components of yTRAP should be readily portable to cells of other species. We envision that the generation of transgenic animals containing yTRAP sensors will eventually enable the detection and tracking of aggregation in live animal models.
Probing Yeast Prions and Modulating Prion Switching
Prion-like mechanisms serve diverse cellular functions in many organisms (Newby and Lindquist, 2013) . We used yTRAP to study yeast prions and uncovered several new insights. First, we constructed the first hyper-inducing prion fusion that is able to convert each cell to the prion state after transient induction. This demonstrates that prion nucleation can be deterministically controlled. As more prion-like elements continue to be discovered, it will be interesting to see whether there exists any similar cross-seeding behavior that may act as natural mechanisms for cellular memory. Second, by screening large libraries of random mutants, we identified many prion-curing alleles that are able to cure wild-type prions in trans. Third, we found that a naturally occurring RNQ1 allele, D288-298 (Resende et al., 2003) , can remodel the wild-type prion after transient exposure. This ''protein conformation recombination'' process could occur in nature to generate additional phenotypic diversity and enhance adaptation in yeast. Similar processes could be at work in humans as well -a natural allele of the human prion protein, PRNP, appears to be protective against prions and grants immunity to prion disease in mice (Asante et al., 2015) . It will be exciting to test more broadly how various alleles and even separate protein components of prion-like assemblies affect their conformations.
Probing the RBP Aggregome
The speed and ease with which quantitative data can be collected using yTRAP combined with genetic screens in yeast makes it an unparalleled platform for discovery in both pathological and functional aggregation. A disproportionately high number of RBPs in the yeast and in the human genomes contain low complexity domains that resemble the amyloid forming regions of prions (March et al., 2016) . The functions and interactions of these low complexity domains have remained mysterious. Mutations in low complexity sequences have emerged as causal factors in neurodegenerative diseases including ALS and MSP (Harrison and Shorter, 2017) . Recently, several ground-breaking papers have demonstrated that these low complexity domains function in phase transitions or liquid-liquid phase separations in the cell (Kroschwald et al., 2015; Riback et al., 2017) .
We are only beginning to understand the difference between functional aggregation and its harmful counterpart. This is partly because we lacked quantitative in vivo assays of aggregation. Herein, we demonstrated that yTRAP can serve as a platform for deciphering aspects of this biology. We performed an unbiased screen for RBP aggregation propensity. The top hit was Hrp1, the homolog of hnRNPA1 in humans for which aggregation is associated with MSP and ALS. Both hnRNPA1 and Hrp1 harbor tandem RNA recognition motifs followed by a low complexity region and a PY (Pro-Tyr) nuclear import sequence. Additionally, both of these proteins shuttle in and out of the nucleus and almost exclusively aggregate in the cytoplasm, similar to other disease-causing RBPs, such as TDP-43 and FUS (Harrison and Shorter, 2017) . Furthermore, pathogenic mutations have been identified in the low complexity regions and nuclear localization sequences for both TDP-43 and FUS. Thus, Hrp1 may resemble its human homologs not only functionally, but also in its mode of aggregation and toxicity.
We used several yTRAP screening techniques to interrogate Hrp1 interactions. We examined the consequences of Hrp1 overexpression across the RBP yTRAP library and found that proteins involved in ribosome biogenesis (Nsr1, Nop58, and Cbf5) became aggregated. This could be indicative of natural cross-talk or co-assembly of these proteins with Hrp1 as part of their normal function or regulation. The same screening methodology can be applied to any aggregation-prone protein of interest to identify putative interaction partners. We also performed a genome-wide overexpression screen to identify genes that could modulate Hrp1 aggregation. We observed that Nab2 can induce Hrp1 aggregation in a non-toxic manner with biological consequences, causing alterations in mRNA cleavage. Considering that these altered processing events elicited no growth defects, an interesting possibility to consider is that Nab2-induced Hrp1 aggregation naturally occurs to regulate its activity and lead to a different set of 3 0 UTR processing sites.
yTRAP and Prion Synthetic Biology
In addition to facilitating new studies and screens for protein aggregation, we propose yTRAP as a platform for synthetic biology, enabling programmable cellular devices to be constructed using prions. To demonstrate this capability, we produced two types of prion-based devices: a synthetic memory device and anti-prion drives.
We demonstrated that a yeast cell can produce and store the memory of heat. Prions have a number of advantages over existing synthetic methods to store information in cells. Their background switching rate can be very low -without overexpression, the spontaneous induction of the [PSI + ] prion is approximately 10 À7 (Lancaster et al., 2010) , on the order of DNA mutations, allowing for high-fidelity storage of information. Furthermore, prion domains can be designed de novo (Toombs et al., 2012) , allowing for the potential expansion to many orthogonal prion memories. yTRAP screens could assist in the selection of multiple orthogonal prion domains and specific prion-switching genes. Using dual or further multiplexed yTRAP, a different function could be assigned to each prion switch. This could allow for a rapid expansion in available tools for the construction of complex cellular devices. The input could be reprogrammed using promoter-based logic to detect other desired stimuli, for example environmental contaminants. The output of yTRAP is also fully programmable; any gene could be used to report on the prion-encoded memory. Anti-prion drives are capable of regulating and curing prion propagation in wild-type populations. Just as gene drives bias the inheritance of DNA so that the drive itself is inherited at an increased frequency (DiCarlo et al., 2015) , phenotypic drives increase the rate at which a phenotype is inherited by progeny. Yeast prions inherently act as phenotypic drives, converting other proteins of the same kind to their own self-templating conformation and being inherited by all meiotic progeny. The diverse phenotypes conferred by microbial prions could be controlled using anti-prion drives. As more prions are discovered and designed de novo, the toolkit of synthetic biology components will grow.
Concluding Remarks
It is becoming increasingly clear that protein aggregation plays key roles in cellular processes, as wide ranging as disease initiation and progression, signaling, and evolution. yTRAP serves both as a means for engineering new tools and as a platform for discovery in natural aggregation phenomena.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Majumdar, A., Cesario, W.C., White-Grindley, E., Jiang, H., Ren, F., Khan, M.R., Li, L., Choi, E.M., Kannan, K., Guo, F., et al. (2012) . Critical role of amyloid-like oligomers of Drosophila Orb2 in the persistence of memory. Cell 148, 515-529. 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Ahmad Khalil (khalil@bu.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Saccharomyces cerevisiae strains used in this study are described in Table S5 . Unless otherwise stated, strains were grown with shaking at 30 C in standard growth media. YPD was 1% yeast extract, 2% peptone, 2% glucose. Complete supplement mixture (CSM) media and CSM drop out media was purchased from Sunrise Science Products and made up as per their instructions, supplemented with 6.7g/L yeast nitrogen base and 2% glucose unless otherwise stated.
METHOD DETAILS
Cloning and vector construction Plasmids used in this study are listed in Table S4 . The basic yTRAP plasmid pGAN147 was constructed by PCR and subsequent Gibson assembly of components into pDML112 (Landgraf et al., 2016) ( Figure S1A ). Gateway cloning was used to insert genesof-interest into pGAN147 to form yTRAP fusions. Gateway cloning was also used to insert genes, such as mutant prion-curing alleles, into pAG-series vectors (Alberti et al., 2007) and their derivatives.
Reverse-yTRAP and dual yTRAP plasmids were constructed with standard cloning techniques and Gibson assembly. Reverse-yTRAP required a TetR-repressible promoter ( Figure S2A ). To obtain a suitable promoter, we generated and screened a small panel of nine variant promoters. Each variant was created by inserting tetO 2 sites at the vicinity of promoter control elements such as TATA-box, transcription factor binding sites and the transcriptional start site of the S. cerevisiae ADH1 promoter. [RNQ + ]
and [rnq - ] yeast strains carrying the tetR-mKate2 yTRAP circuit (pGAN230) were used to screen this panel, and the promoter with the greatest dynamic range was selected for use (pSK221).
To enable dual yTRAP, we constructed a second yTRAP sensor plasmid using a second engineered zinc finger and its paired DNA binding site (Khalil et al., 2012) (Figure S2C ). This second plasmid was generated from pGAN147, exchanging sites of homology from the HO locus to the LEU2 locus to re-target the integration, and NAT r resistance for KanMX.
Prion-inducing fusions were generated by PCR and subsequent Gibson assembly into the estradiol-inducible plasmid pHES835 (Aranda-Díaz et al., 2017) . pJMB101 harbors the estradiol-responsive transcription factor composed of the chimeric ZEM regulator (Zif268 -Estradiol Receptor ligand binding domain -Msn2 activation domain) (Aranda-Díaz et al., 2017) . For heat-inducible expression, the estradiol-responsive promoter was swapped for the SSA4 promoter by standard cloning techniques.
RBP yTRAP sensors were constructed using Gateway cloning. Individual plasmids were prepared from the yeast MORF collection (movable ORF; GE Dharmacon, Cat# YSC3867) and cloned into the yTRAP destination plasmid pGAN147. The 48 genes that were not available in the MORF collection were amplified from the yeast genome by PCR and cloned separately. Estradiol-inducible Hrp1 was constructed using pHES835 as above and induced using the ZEM regulator. To induce the GAL1 promoter using estradiol, as was done for the aggregation propensity screen and genome-wide screen for modulators of Hrp1 aggregation, the GEM regulator (Gal4 DNA binding domain -Estradiol Receptor ligand binding domain -Msn2 activation domain) was used instead (Aranda-Díaz et al., 2017) .
Yeast strains and growth conditions
Yeast strains used in this study were primarily derived from YJW508 (MATa, 112; (MATa, 112; (MATa, 112; ]; [RNQ + ]). A complete list of strains generated in this study is shown in Table S5 . Growth media was complete supplement mixture (CSM) media or CSM lacking certain amino acids with either 2% glucose, 2% galactose, 2% raffinose, or 2% glycerol supplemented as the carbon source (glucose was used unless otherwise specified below). YPD plates used for prion curing contained 5 mM guanidine hydrochloride. Media was supplemented with 50 mg/mL adenine hemisulfate (Sigma Aldrich, A9126) to eliminate the color of ade-cells, which otherwise interferes with fluorescence readings. Yeast transformations were conducted using a lithium acetate competent cell protocol as previously described (Knop et al., 1999 ] strains were also confirmed to display a change in color on rich media and grow on SD-Ade media.
Endogenous tagging of yeast genes with mNeonGreen was achieved by homologous recombination with long homology regions ($300 bp) generated by PCR, as previously described (Landgraf et al., 2016) . mNeonGreen was amplified with a NAT resistance cassette and assembly PCR was used to add the relevant homology regions at the terminus before transformation. Proper integration was confirmed by colony PCR.
Flow cytometry
Cells were diluted 100-fold from overnight cultures in CSM media into fresh media, and incubated 6 hr at 30 C to reach exponential growth before measurement. Unless otherwise stated, 10,000 -50,000 events were acquired using a MACSQuant VYB cytometer with a 96-well plate platform (Miltenyi Biotech), and data was processed using FlowJo. Events were gated by forward and side scatter, and median fluorescence values were calculated. In order to exclude dead cells from analysis, 10 ug/mL propidium iodide (Sigma Aldrich Cat. No. P4864) or 1 ug/mL DAPI (Roche Diagnostics Cat. No. 10236276001) stain was used. The B1 channel (525/50 filter) was used to measure green fluorescence. The Y3 channel (661/20 filter) was used to measure red fluorescence or propidium iodide stain. The V1 channel (450/50 filter) was used to measure DAPI.
Western blotting and densitometry 1OD unit of log phase cells were collected by centrifugation and protein was extracted with the following TCA extraction method. Cells were resuspended in 1 mL dH 2 O, followed by the addition of NaOH to a final concentration of 0.25 M and 2-mercaptoethanol to a concentration of 1% (v/v), and were incubated on ice 15 min. TCA was added to a concentration of 6.5% (w/v) and samples were incubated a further 10 min on ice before centrifugation at 12,000 rcf to collect precipitated protein. Precipitate was dissolved in HU buffer (200 mM Tris HCl pH 6.8, 8 M urea, 5% SDS, 1.5% DTT, bromophenol blue) and incubated at 65
C for approximately one hour. Samples were separated by SDS-PAGE and transferred to nitrocellulose membranes using the Invitrogen iBlot2 (7 min transfer). For primary antibodies, Santa Cruz Mouse monoclonal anti-HA (sc-7392) was used to blot against the 6xHA epitope on the synTA. Rabbit polyclonal anti-PGK1 (ABIN568371; antibodies-online.com) was used as a loading control. For fluorescent secondary antibodies, LI-COR IRDye 800CW donkey anti-mouse (product 926-32212) and LI-COR IRDye 680RD donkey anti-rabbit (product 926-68073) were used. Blots were imaged with the LI-COR Odyssey system. Band quantification / densitometry was performed using the Image Studio Lite software.
SDD-AGE SDD-AGE was adapted from previous protocols (Halfmann and Lindquist, 2008) . Saturated 4mL cultures of yeast grown in YPD were centrifuged and resuspended in 250 mL of lysis buffer (100mM Tris pH 8.0, 20mM NaCl, 10mM beta-mercaptoethanol, 1:50 diluted protease inhibitors (Fisher xyz), 0.025 units/mL benzonase). Approximately 250 mL of acid-washed beads were added, and samples were lysed by bead-beating in a QIAgen sample lyser (10 min, 60Hz) using frozen tube holders. Supernatant was collected after a 5 min centrifugation at 500 rcf, 4 C. 4x sample buffer (2xTAE, 20% glycerol, 8% SDS, bromophenol blue) was diluted 4-fold into lysate, incubated at room temperature for 4 min, and loaded into SDD-AGE gels (1.5% agarose, 1x TAE, 0.1% SDS). Gels were run for 4-6 hr at 40 V, and transferred to nitrocellulose membranes by overnight liquid transfer. Membranes were treated as western blots above. Santa Cruz Mouse monoclonal anti-HA (sc-7392) was used as the primary antibody, and Sigma Aldrich HRP-conjugated rabbit anti-mouse IgG (A-9044) was used as the secondary antibody.
Agar plate fluorescence photography Photographs were collected using a Bio-Rad Chemi-Doc MP. Colonies were grown for 2 days at 30 C on agar yeast CSM plates and imaged on the second day. For green fluorescence, the blue LED was used for excitation, and the 530/28 nm filter for emission. For red fluorescence, the green LED was used for excitation, and the 605/50 nm filter for emission. The Bio-Rad Image Lab software was used for false-coloring. Overlays were assembled using the transparency parameter in Adobe Photoshop.
Epifluorescence microscopy Epifluorescence images of Sup35 yTRAP sensors were taken at 100x magnification (Plan Apo 100x oil objective, NA 1.4) using an Eclipse Ti-E inverted microscope (Nikon Instruments, Inc.). Images were acquired in DIC and in fluorescent (GFP) channels. Filters and light sources were automatically controlled by the supplier's software (NIS-Elements Advanced Research).
For microscopy on induced / uninduced RBPs the following protocol was used: overnight cultures were diluted into CSM media at OD = 0.1 and grown for 2 hr at 30 C prior to induction with 100 nM estradiol. Induction was continued for at least 4 hr before imaging. Cells were imaged live within ten minutes of their preparation on glass slides. Epifluorescence images were taken at 100x magnification (Plan Apo Lambda 100X oil objective, NA 1.45) using an Eclipse Ti-E inverted microscope and a CCD camera (Andor technology). Bright field (BF) images were collected along with images in green and red fluorescence channels. Images were processed with ImageJ, and linear intensity transformations were set identically for induced and uninduced samples.
Fluorescence plate reader measurements
Measurements were performed using an Infinite M1000 PRO microplate reader (Tecan Group Ltd.). Cells were grown to saturation in CSM media. 200 mL of triplicate saturated cultures were added to clear-bottom, flat, black microtiter plates (Corning Product #3631). Absorbance at 600 nm was collected to measure cell density, raw fluorescence (ex. 488/5 nm, em. 520/5 nm) was collected to measure yTRAP signal, and fluorescence was calculated by normalizing raw fluorescence by absorbance.
Isolation of Swi1, Mot3-PrD, and New1-PrD prion states Galactose-inducible plasmids for Swi1, Mot3-PrD, and New1-PrD were introduced into sensor strains for the same protein. Cells were grown overnight in CSM ura drop-out media supplemented with galactose to induce expression. Subsequently, cultures were plated on glucose agar plates. Colonies on agar plates were photographed in the green fluorescent channel to assess prion state. Low-fluorescence colonies were picked and streaked for further testing. Colonies were confirmed to contain a prion by streaking on guanidine hydrochloride plates -those that were cured and returned to a bright fluorescent state were [PRION + ] switched cells.
Relative aggregation measurement
To measure relative aggregation of Htt-Q25 and Htt-Q103 ( Figure S1G ), triplicate sensor strains for each protein (yGAN016-017) were diluted 100-fold from overnight CSM media cultures and grown for 6 hr at 30 C. yTRAP signal was measured by flow cytometry. Relative aggregation was calculated as the average of the least-aggregated samples divided by each sample: Relative aggregation = (average Htt-Q25 yTRAP signal) / (yTRAP signal).
To measure relative aggregation of Q-/N-rich proteins in response to Htt overexpression ( Figure 1E ), yTRAP sensor plasmids for these protein domains were transformed into cells containing integrated galactose-inducible Huntingtin exon 1 harboring 103 glutamine residues (Htt-Q103) or into an identical strain lacking Htt-Q103 overexpression constructs (producing yGAN018-029). Triplicate cultures were grown overnight to saturation in CSM media containing raffinose as a carbon source. The following day, each strain was diluted 50-fold into raffinose media and, separately, media containing galactose to induce Htt-Q103. Cells were grown for 6.5 hr at 30 C and then fluorescence was measured by flow cytometry. Aggregation in Htt-Q103-induced samples was calculated by dividing median fluorescence of each strain in raffinose by median fluorescence in galactose. To normalize for the effect of carbon source, the raf/gal ratio of Htt-expressing cells was divided by the raf/gal ratio of control cells, yielding the final relative aggregation value: Relative aggregation = (yTRAP signal of Htt-expressing cells in raffinose / yTRAP signal of Htt-expressing cells in galactose) / (yTRAP signal of no-Htt cells in raffinose / yTRAP signal of no-Htt cells in galactose).
Guanidine-curing time course
The dual PSI / RNQ sensor strain (ySK293) was diluted to OD 0.001 into triplicate 50 mL cultures of CSM media with 5mM guanidine hydrochloride. The zero time point negative control was diluted to OD 0.001 without guanidine hydrochloride. After 12 hr of shaking at 30 C in 500 mL baffled flasks, 50 mL samples were collected from each of the curing flasks and diluted 100-fold into 5 mL of fresh CSM medium lacking guanidine hydrochloride to halt prion curing. Additional samples were collected every two hours until 22 hr after guanidine treatment started. In addition to collecting final, 22 hr samples by dilution into medium lacking guanidine hydrochloride, samples were also diluted 100-fold into fresh media containing 5 mM guanidine hydrochloride to continue curing. The following day, after a total of 36 hr of growth, all samples had grown to stationary phase and were diluted another 100-fold in fresh medium lacking guanidine hydrochloride. After 6 hr of growth, the prion status was assessed by flow cytometry as described above, gating to distinguish populations of prions. One recovered culture that had been treated with guanidine hydrochloride for 16 hr was spread on an agar plate for photography.
Inducing [PSI + ] with transient expression of prion fusions
Duplicate colonies harboring estradiol-inducible prion domains and fusions were picked into 500 mL of non-inducing CSM media and grown overnight at 30 C with shaking in a deep-well 96 well plate. Saturated cultures were diluted 100x into 500 mL CSM media with or without 100 nM estradiol. After 24 hr of growth, cultures were centrifuged 5 min at 2000 rcf, and media was beat off. Cultures were resuspended in 500 mL of fresh media, then diluted 100x into non-inducing media and grown 24 hr further. Cultures were then diluted 100-fold and grown 6 hr to reach log phase before measurement by flow cytometry to assess prion state. This allows for 8 to 12 generations of growth in non-inducing conditions, so that only heritable changes in prion state were assessed.
Heat induction and memory experiments
Cultures were grown at 25 C in CSM media. Cultures were pre-screened with flow cytometry for background switching because of leakiness of the SSA4 promoter. Only [psi - ] cultures were used in the experiment. Saturated cultures were diluted to OD 600 of 0.02 in 96-well PCR plates. Cultures were grown for 4 hr at 25 C, then transferred to an Eppendorf PCR instrument (Mastercycler Pro) incubating a gradient of temperatures for 2 hr. After heat treatment, samples were returned to 25 C for overnight growth. The next day, cultures were diluted 1000x into fresh media and grown 24 hr at 25 C. After this, cultures were diluted 100x further into fresh media and grown 6 hr at 25 C to log phase before flow cytometry measurement as above to assess prion state.
Selection of prion-curing alleles
We used a previously described variomics library (Huang et al., 2013) . The mutant libraries for Sup35 and Rnq1 were grown and sporulated in liquid media. To sporulate, diploids were inoculated to a final OD 600 of 0.5 in 50mL of sporulation media (1% potassium acetate, 0.005% zinc acetate). They were incubated with shaking for 5 days at 25 C. MATa spores containing the mutant plasmid and chromosomal deletion were selected by growing in liquid media (CSM media -arg-his-leu-ura + 60 ug/mL canavanine + 200 ug/mL G418, supplemented with glucose) for 5 generations. For each step, at least 2 million viable cells were used to maintain 10-fold coverage of the theoretical diversity of 200,000 mutants. ] prions. 6 million mutant spores were mixed with 2-fold excess of yTRAP sensor cells to mate. These were plated on YPD agar plates and incubated at 30 C for 16 hr. Cells were then scraped from the plate and collected in dH 2 O. Aliquots were plated on diploid-and haploid-selective media to determine the mating efficiency. Diploid selective media was CSM media lacking uracil +100 mg/mL nourseothricin + 200 mg/mL G418, supplemented with glucose (nourseothricin selects for the yTRAP sensor, G418 selects for the chromosomal deletion, media lacking uracil selects for the mutant plasmid covering the chromosomal deletion). Haploid selective media was CSM media -his-leu-ura+200 mg/mL G418, supplemented with glucose. Diploid cells containing both the mutant plasmid and the yTRAP sensor were present in larger numbers than haploids containing only the mutant plasmid, so we estimated that mating was greater than 50% efficient. The pool of scraped cells was diluted in diploid-selective media and grown 6 hr to OD 1.0. At this point, cells were diluted 100-fold into diploid-selective media and grown a further 13 hr until FACS sorting (OD $1.0).
FACS sorting was performed using a FACS Aria II (BD Biosciences). The top 0.005% of most fluorescent cells (indicating a nonprion state) were collected (300-400 cells). 5 million -9 million cells were examined in each pool. After sorting, cells were recovered for 2.5 hr in CSM media lacking ura. 100 mg/mL nourseothricin and 200 mg/mL G418 were then added to maintain selection for diploid cells. Cultures were shaken 2 days at 30 C until reaching saturation. Plasmids were purified from each sample as previously described . Plasmids were amplified by electroporation into bacteria followed by subsequent miniprep.
Mutant plasmids were retransformed into haploid [PSI
] yTRAP sensor strains for a second round of selection. Empty plasmids were also transformed separately to serve as negative controls. Transformants were grown in selective liquid media for 40 hr with intermittent dilution to keep cells from reaching stationary phase, and then subjected to a second FACS sort. Collection gates were set so that all cells from control strains containing empty plasmids would be excluded, and only cells with greater fluorescence were collected. 20,000 cells were collected for both libraries and recovered as before. Plasmids were purified from yeast and transformed into bacteria. 24 clones of each library were prepped and sequenced (Table S1 ).
Prion-curing by transient expression of mutant alleles
Estradiol-inducible mutant plasmids were transformed into the PSI / RNQ dual-sensor strain yGAN036. The strain also contains a pAG303GPD-Sup35C plasmid, which eliminates toxicity from Sup35NM expression. Estradiol induction was performed as follows: overnight cultures in CSM media lacking uracil were diluted 1000x into CSM media lacking uracil supplemented with 5 nM estradiol. After 24 hr of induction, cultures were measured by flow cytometry to determine effects on solubility during overexpression (Table S1 ). Cultures were also diluted 1000x into fresh media lacking estradiol to recover and examine heritable effects. After 24 hr of recovery, cultures were diluted 100x into fresh media and grown 6 hr before measurement by flow cytometry (Figures 4B and 4C ; Table S1 ).
The Saccharomyces Genome Database was used to search for known strains that harbor our selected mutant prion-curing alleles in SUP35 and RNQ1. The Rnq1 D288-298 mutation was harbored in 4 of the 45 available yeast strains: 217_3, PW5, DBVPG6044, and YJM789.
Anti-prion drive mating, sporulation, and tetrad dissection Plasmids harboring the 'drive cassettes' (pGAN257-261) or wild-type controls were transformed into MATa sensor strains for the respective prion (forming yGAN060-064). The anti-PSI drive was derived from a clone with high expression of the drive cassette. Strains used to test the anti-PSI drive strain harbored a constitutive Sup35C construct to prevent toxicity from overexpression of Sup35NM. To test drives, anti-prion drive strains were mated to 'tester strains' (yGAN065 for PSI or yGAN066 for RNQ). Mating was conducted by spreading a water-suspended colony of the tester strain onto agar YPD plates and letting it dry. A separate plate with large, spotted colonies of the drive-containing strains was replica plated onto the same YPD plate, and incubated for 6 hr at 30 C to allow for mating. The YPD plate was then replica plated onto his and leu drop-out agar plates, allowing only diploids to grow. Diploid colonies were streaked once onto the same media, then picked into 5mL pre-sporulation media (20 g/L bacto-peptone, 10 g/L yeast extract, 40 g/L glucose, 100 mg/L adenine hemisulfate) and grown at 30 C overnight. Overnight cultures in pre-sporulation media were centrifuged and resuspended in 5 mL dH20 to wash. This process was repeated for a total of 3 washes before cells were resuspended in 200 mL of dH20. 50 mL was spotted onto agar SPO plates (1 g/L potassium acetate, 50 mM uracil, 100 mM tryptophan, 50 mg/L leucine, 25 mg/L of every other natural amino acid, 25 mg/L adenine, 2.5 mg/L p-aminobenzoic acid, and 20 g/L agar). Plates were incubated 2 nights at 30 C to sporulate. Following this incubation, a few mg of cells were picked with a pipet tip and resuspended into enzyme mix (1 M sorbitol, 0.1 M EDTA, 10 mg/mL zymolyase). This was quickly vortexed to mix and left at room temperature 5-10 min. A sterile loop was used to streak a line of cells onto an agar YPD plate. Tetrads were dissected using a Singer MSM dissection microscope. Dissected spores were grown 2 days at 30 C and then arrayed into cultures in 96 well plates. Spores were spotted onto CSM media agar plates to image fluorescence, indicative of prion state. They were also spotted on CSM agar plates lacking leucine to determine whether or not each haploid inherited the gene drive cassette (Figures 5B and 5C ). Spores were also streaked onto guanidine hydrochloride plates to cure their prions and spotted likewise to compare to uncured cultures. All samples were measured by flow cytometry, only three sets of spores for each sample were spotted and photographed.
Supernatant/pellet fractionation of Rnq1 Supernatant/pellet fractionation and blotting was conducted as previously described for Rnq1 (Bradley et al., 2002) . 100 mL YPD cultures were inoculated with overnight yeast cultures to OD 0.1, and grown 6 hr to OD 1.0. Cells were resuspended in 100 mL lysis buffer (50 mM Tris pH8.0, 150 mM NaCl, 0.2% Triton X-100, and Halt protease inhibitors (ThermoFisher Scientific 78430)). 750 mL of lysis buffer / glass bead slurry was added, and cells were vortexed 8 times for 10 s each to lyse. Between each vortex cycle, cells were incubated on ice for 2 min. Tubes were centrifuged 10 min at 10,000 g at 4 C. The supernatant was taken as the total lysate. BCA assays were conducted to determine protein concentration and normalize samples with lysis buffer. 1 mg of protein was added to centrifuge tubes and samples were centrifuged for 30 min at 280,000 g at 4 C. The supernatant fraction was collected, and the pellet was resuspended in lysis buffer before loading on an SDS-PAGE gel. Western blots were probed with a polyclonal rabbit antibody against Rnq1 (Bradley et al., 2002) and an anti-rabbit HRP-conjugated secondary antibody (Sigma Aldrich A0545).
Screen of RBP sensor library members for aggregation propensity Each member of the yTRAP RBP sensor library was transformed with a high copy-number plasmid containing an expression cassette for the same RBP, regulated by the GAL1 promoter. yEHA122, which harbors an integrated estradiol-sensitive transcription factor that binds and activates the GAL1 promoter in the presence of estradiol (from plasmid pEHA840), was mated to each sensor strain. Diploids were selected on agar plates lacking leucine and uracil, supplemented with 100 mg/mL nourseothricin. Colonies were pinned one more time on selective agar plates to purify diploids. Four individual diploid patches were picked for measurement. Each strain was grown to saturation in CSM media lacking uracil to select for the overexpression plasmid. Overnight cultures were diluted 100-fold in fresh media and grown for 3 hr to log phase. Cultures were then split, 50 mL was diluted 1:1 into non-inducing media, and 50 mL diluted 1:1 into inducing media (final estradiol concentration of 100 nM). Cultures were grown for a further 4 hr at 30 C, and measured using flow cytometry as described above. Induced samples were measured immediately following uninduced controls to minimize time delays in measurement.
Screen for aggregation of RBP sensor library during HRP1 overexpression The HRP1 ORF was cloned into the estradiol-inducible plasmid using Gibson assembly, yielding pEHA655. This plasmid was integrated into the yeast genome to produce yEHA125, which also contains the estradiol-responsive transcription factor ZEM. yEHA125 was mated to the RBP sensor library in 96-well plates and diploids were selected on agar plates lacking leucine and uracil, supplemented with 100 mg/mL nourseothricin. Colonies were re-streaked one more time on selective agar plates to purify diploids. Diploids were picked into CSM media and grown overnight. Cultures were then diluted 100-fold into CSM media supplemented with 100 nM estradiol, or media lacking estradiol as a negative control. After 6 hr of growth and induction at 30 C, cultures were measured using flow cytometry as described above.
Yeast growth curve assays
Cultures were grown independently in 96-well plates overnight, then diluted to an OD of 0.03 in media with or without estradiol. 70 mL of each diluted culture was added to a 384-well plate and measured using a Biotek Epoch2 microplate reader at 30 C. Absorbance at 600nm was collected every 15 min to track cell growth.
Genome-wide screen for Hrp1 modulators The Hrp1 yTRAP sensor strain (yEHA415) was transformed with the estradiol-sensitive transcription factor GEM (pEHA840) to generate yEHA244. This strain was mated in an arrayed format to the yeast Flexgene library (Hu et al., 2007) . The Flexgene library consists of yeast strains harboring every ORF under an inducible promoter in a low copy number plasmid (pBY011). All Flexgene strains were grown to log phase in CSM media lacking uracil and mixed 1:1 with a log-phase yEHA244 culture. After 3 hr of incubation at 30 C to allow for mating, 5 mL of the cell mixture was spotted on selective plates lacking leucine and uracil, supplemented with 100 mg/mL nourseothricin. After 2 days of growth the mated library was pinned once again on selective agar plates to purify diploids. After another day of growth, colonies were pinned into selective liquid media lacking leucine and uracil and grown to saturation.
To measure the change in Hrp1 solubility, 4 mL of saturated diploid cultures were diluted into 200 mL of selective media lacking uracil supplemented with 100 nM estradiol and grown for 15 hr at 30 C. After that period, a further 100-fold dilution was made in the same media to continue induction of the library. After 4 more hours of induction, Hoechst 33342 was added to a final concentration of 2 ng/mL to stain dead cells for exclusion. 96-well plates were measured by flow cytometry as described above (6000 events were collected per sample). Results are summarized in Table S3 .
Out of a total of 5,737 flow cytometry measurements on library members, 85 readings showed low cell counts indicative of particularly poor growth and were discarded. Of the remaining 5,652 readings, 47 were found to be statistically significant hits falling 3 standard deviations from the mean. 30 of these yielded a drop in yTRAP signal and 17 showed an increase in yTRAP signal. 13 strains showing no significant change in Hrp1 yTRAP signal were used as controls for the immediate secondary validation of hits. These 60 strains were picked freshly from the frozen yeast Flexgene library and mated to the Hrp1 yTRAP sensor strain (to re-test their effect on aggregation) and, separately, to a strain harboring an mNeonGreen tag on its endogenous Hrp1 (to test their effect on total Hrp1 levels). Growth curves were collected for these 60 diploids during induction of the ORF library member in technical quadruplicates (Table S3) . Proteins causing severe growth defects upon overexpression or changes in the total levels of Hrp1 were excluded from future analysis. Additionally, proteins with an annotated role in nuclear/cytoplasmic transport were excluded because they were likely false positives that affected yTRAP signal without affecting aggregation. This left us with 11 proteins that caused a drop in Hrp1 yTRAP sensor signal. These proteins were tagged with mKate2 by Gibson assembly and integrated into the yeast genome under an estradiol-inducible promoter to reduce the noise coming from episomal expression. Three proteins (Sto1, Tfb1, and Yil055c) that increased Hrp1 yTRAP signal upon overexpression were also included in microscopy experiments. These 11 overexpression strains, along with a strain expressing mKate2-only as a control, were mated with the Hrp1 yTRAP sensor strain and strain harboring an mNeonGreen tag on endogenous Hrp1. Diploids were induced for a third round of validation to confirm the effect of the overexpressed protein on Hrp1 yTRAP signal and lack of effect on total levels of Hrp1. Microscopy was conducted on these strains to observe the effect of overexpression of the hits on endogenous Hrp1. This procedure is summarized in Table S3 .
3
0 UTR PCR (RACE) experiments Rapid Amplification of cDNA Ends (RACE) was used to detect alterations in mRNA polyadenylation sites in the presence of Nab2 overexpression. A strain harboring estradiol-inducible Nab2-mKate2 (yEHA173) and a control strain harboring estradiol-inducible mKate2 (yEHA188) were grown overnight in CSM media. They were diluted 100-fold into fresh CSM media supplemented with 100 nM estradiol and grown for 6 hr at 30 C. 5 OD units of cells were harvested and frozen in liquid nitrogen. RNA was extracted using the YeaSTAR RNA kit (Zymo Research, Cat# E1004). cDNA was prepared using the SuperScriptIII kit (ThermoFisher Scientific, Cat# 18080051), using dT 18 NV-as the primer to amplify from the start of polyA tails. 1 mL of cDNA was used in each RACE PCR reaction. Internal control primer pairs were amplified in separate reactions simultaneously.
QUANTIFICATION AND STATISTICAL ANALYSIS
FlowJo was used to extract median fluorescence values from flow cytometry measurements. Microsoft Excel and GraphPad Prism software were used to process data. Statistical details such as N and error calculations are provided in figure legends.
DATA AND SOFTWARE AVAILABILITY
Requests for additional data should be directed to and will be fulfilled by the Lead Contact, Ahmad Khalil (khalil@bu.edu). (A) Schematic of the yTRAP sensor genetic construct. This consists of (1) a yTRAP fusion between a gene-of-interest (GOI) and a synthetic zinc finger (ZF)-based transcriptional activator (ZF-43-8) (Khalil et al., 2012) , and (2) a reporter harboring 8x ZF binding sites upstream of a minimal promoter driving the expression of a mNeonGreen reporter gene. This plasmid is integrated as a single copy into the HO locus of the yeast genome. SV40 NLS, SV40 nuclear localization sequence; VP16, Herpes simplex virus VP16 transcriptional activation domain; PKI NES, protein kinase inhibitor nuclear export sequence; SUP35 term, SUP35 terminator; minCYC1, minimal CYC1 promoter; ADH1 term, ADH1 terminator. fractionated for each spore and a guanidine-cured control. Rnq1 in its prion state is known to readily pellet, while in the non-prion state it remains in the lysate supernatant (Bradley et al., 2002) . (F) The top eleven hits that decreased Hrp1 yTRAP signal without altering its steady-state level were tagged with mKate2 and induced with estradiol. Red fluorescence was measured using flow cytometry to determine the total level of induction (n = 2, error bars, SD).
(B) Retesting effects of genome-wide screen hits on Hrp1 steady-state levels and yTRAP signal. mKate2-tagged proteins were overexpressed in either Hrp1 yTRAP sensor strains or strains harboring an endogenous Hrp1 mNeonGreen tag. Flow cytometry was used to measure fluorescence before and after induction, and fold-change was calculated. Fold change of the Hrp1 yTRAP sensor is shown in green. Fold change of steady-state levels of Hrp1 is shown in black (n = 2, error bars, range).
(C) Flow cytometry on Nab2 overexpression. Red fluorescence generated by Nab2-mKate2 is plotted on the x axis. Top: Green fluorescence due to an mNeonGreen tag on endogenous Hrp1 is plotted on the y axis to track changes in steady-state levels of Hrp1. Bottom: Hrp1 yTRAP signal is plotted on the y axis to track changes in Hrp1 aggregation. Uninduced samples are colored gray. Samples overexpressing Nab2-mKate2 are colored red.
